Advertisement

Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML
Posted: 05/16/2022 | By: Matthew Stenger

Question 1 of 5

The addition of ivosidenib to azacitidine resulted in significant improvements in:

Choose 1

A
Event-free survival and overall survival in previously treated patients
B
Event-free survival only in newly diagnosed patients
C
Event-free and overall survival in newly diagnosed patients
D
None of the above

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage